Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Glycomics/Glycobiology Market 2017-2025 - Increase in Number of Biotechnology & Biopharmaceutical Industries is Driving the Market -

Research and Markets
Posted on: 02 Feb 18

The "Global Glycomics/Glycobiology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to's offering.

The global glycomics/glycobiology market was valued at US$ 657.3 million in 2016, and is expected to reach US$ 1,891.9 million by 2025, expanding at a CAGR of 12.4% from 2017 to 2025.

It is studied that, in the base year 2016, drug discovery & development was the major revenue generating segment because increase in R&D activities for the development of novel therapies and higher number of unmet needs are primarily driving the market growth.

The glycobiology market is currently dominated by North America due to technological advancement, higher investment in R&D activities and presence of large number of biotechnology, biopharmaceutical industries and research institutes. However, due to increasing government investments in the life sciences sector and increasing partnership of key players with local manufacturer, and rapidly expanding life science industries in this region the market will witness phenomenal growth.

For the purpose of this study, the glycomics market is segmented on the basis of product type:


  • Glycosidases
  • Glycosyltransferases
  • Neuraminidases
  • Sialyltransferases
  • Sulfatases
  • Carbohydrate kinases


  • Antibody arrays
  • HPLC
  • Lectin arrays
  • Mass spectrometers


  • Glycan labeling kits
  • Glycan purification kits
  • Glycan release kits


  • Glycoproteins
  • Monosaccharides
  • Oligosaccharides

Currently, instruments held the largest market share due to higher costs and its prime role in glycobiology. It is anticipated that enzymes will show the highest growth during forecast period due to increasing use in research and development activities.

Key Market Movements:

  • Factors such as increase in number of biotechnology and biopharmaceutical industries, technological advancement and increasing applicability of glycobiology in drug discovery and development are major factors that driving the growth of glycomics/glycobiology market globally.
  • Increasing demand of personalized medicines for the treatment of several severe chronic diseases will drive the glycomics/glycobiology market growth during forecast period.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Glycomics/ Glycobiology Market Analysis

Chapter 4 Global Glycomics/ Glycobiology Market, by Product Type

Chapter 5 Global Glycomics/ Glycobiology Market, by Application

Chapter 6 Global Glycomics/ Glycobiology Market, by Geography

Chapter 7 Company Profiles

  • Agilent Technologies
  • Bruker Corporation
  • Danaher Corporation
  • Merck KGaA
  • New England Biolabs
  • ProZyme, Inc.
  • R&D Systems, Inc.
  • Shimadzu Corporation
  • Takara Bio, Inc.
  • Thermo Fisher Scientific
  • Waters Corporation

For more information about this report visit

View source version on

Business Wire

Last updated on: 02/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.